Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-03-01
1998-01-13
Loring, Susan A.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241331, 4241411, 4241581, 5303873, 5303881, 53038823, A61K 39395, C07K 1600, C07K 1618, C07K 1624
Patent
active
057076227
ABSTRACT:
Anti-IL-8 monoclonal antibodies are described for use in diagnostic applications and in the treatment of inflammatory disorders such as inflammatory bowel disease and bacteria pneumonias.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
Boylan et al., "Interleukin-8 is a major component of pleural liquid chemotactic activity in a rabbit model of endotoxin pleurisy" Amer. J. Physiol. 267(2):L137-L144 (1994).
Stockley, Robert A., "Role of Inflammation in Respiratory Tract Infections" Amer. J. Med. 99(Supp. 6B): 8S-13S (1995).
Raab, Y et al, Gut, 34:1203-1206, 1993.
St. John, R.C. et al, Chest, 103:932-943, 1993.
Boylan, A. Metal, J. Clin Invest, 89:1257-1267, Apr. 1992.
Broaddus, V.C. et al, Am Rev. Respir. Dis, 146:825-830. 1992.
Cross et al., "Choice of Bacteria in Animal Models of Sepsis" Inf. & Immunity 61(7) :2741-2747 (Jul. 1993).
Harris et al., "Therapeutic antibodies--the coming of age" Tibtech 11:42-44 (Feb. 1993).
Herbert et al., "Interleukin-8: A Review" Cancer Investigation 11(6) :743-750 (1993).
Ko et al., "A sensitive enzyme-linked immunosorbent assay for human interleukin-8" J. Immunol. Methods 149:227-235 (1992).
Mulligan et al., "Inhibition of Lung Inflammatory Reactions in Rats by an Anti-Human IL-8 Antibody" 150(12) :5585-5595 (Jun. 15, 1993).
Sartor, R. Balfour, "Animal Models of Intestinal Inflammation--Relevance to Inflammatory Bowel Disease", Inflammatory Bowel Disease (Chapter 18), McDermott et al., New York:Elsevier pp. 337-353 (1992).
Sekido et al., "Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8" Nature 365:654-657 (Oct. 14, 1993).
St. John et al., "Immunologic Therapy for ARDS, Septic Shock, and Multiple-Organ Failure" Chest 103:932-943 (1993).
Sticherling et al., "Immunohistochemical studies on NAP-1/IL-8 in contact eczema and atopic dermatitis" Arch. Dermatol. Res. 284:82-85 (1992).
Sticherling et al., "Production and Characterization of Monolclonal antibodies Against the Novel Neutrophil Activating Peptide NAP/IL-8" J. Immunol. 143(5) :1628-1634 (Sep. 1, 1989).
Wada et al., Jouranl of Experimental Medicine 180:1135-1140 (Sep. 1994).
Waldman, Thomas A., "Monoclonal Antibodies in Diagnosis and Therapy" Science 252:1657-1662 (Jun. 21, 1991).
Higa et al., "Attenuation of epithelial injury in acute experimental colitis by immunomodulators" Eur. Journal of Pharmacology 239:171-176 (1993).
Lichtiger et al., "Cyclosporine in severe ulcerative colitis refractory to steroid therapy" New England J. of Medicine 330(26) :1841-1845 (1994).
Fong Sherman
Hebert Caroline Alice
Kim Kyung Jin
Leong Steven R.
Genentech Inc.
Loring Susan A.
Love Richard B.
LandOfFree
Methods for treating ulcerative colitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating ulcerative colitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating ulcerative colitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-324067